The global beta-lactam and beta-lactamase inhibitors market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Beta-lactam antibiotics are a class of antibiotics consisting of all antibiotic agents that contain a beta-lactam ring in their molecular structures. This includes penicillin derivatives, cephalosporins, monobactams, and carbapenems. These are the antimicrobial substances or compounds that fight against bacterial infections and sometimes with protozoan infections. In addition, these medications either kill the bacteria directly or stop the bacteria from growing. Furthermore, there are many new drugs in the pipeline, which are expected to be launched during the forecast period and will create an opportunity for the global beta-lactam and beta-lactamase inhibitors market players.
To Request a Sample of our Report on Global Beta-Lactam and Beta-Lactamase Inhibitors Market: https://www.omrglobal.com/request-sample/beta-lactam-and-beta-lactamase-inhibitors-market
The major factors that propel the growth of the global beta-lactam and beta-lactamase inhibitors market include the increased consumption in low- and middle-income countries (LMICs), and the rise in prevalence of infectious diseases. In addition, the development of novel approaches for new beta-lactam and beta-lactamase inhibitors for treating bacterial infections and a large number of clinical trials further drive the market growth. In addition, the discovery of advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer significant profitable opportunities for the market players during the forecast period, and hence increase the global beta-lactam and beta-lactamase inhibitors market share.
The global beta-lactam and beta-lactamase inhibitors market analysis includes some of the key market players such as Abbott Laboratories, Allergan Plc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Merck & Co. Inc., and Novartis International AG (Sandoz), among others.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Abbott Laboratories, Allergan Plc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Merck & Co. Inc., and Novartis International AG (Sandoz), among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Beta-Lactam and Beta-Lactamase Inhibitors Market is Available at: https://www.omrglobal.com/industry-reports/beta-lactam-and-beta-lactamase-inhibitors-market
Global Beta-Lactam and Beta-Lactamase Inhibitors Market by Segment
By Drug Class
• Penicillin
• Cephalosporin
• Carbapenem
• Monobactam
• Combination
By Disease
• Urinary Tract Infection
• Respiratory Infection
• Skin Infection
• Complicated Urinary Tract Infection (cUTI)
• Complicated Intra-Abdominal Infections (cIAI)
• Nosocomial Pneumonia
• Blood Stream Infection
• Other
By Route of Administration
• Oral
• Intravenous
• Other
Global Beta-Lactam and Beta-Lactamase Inhibitors Market by Regional Analysis
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
